Significance and Implications of Capillaritis during Acute Rejection of Kidney Allografts

Transplantation

Volumn 89, Issue 9, 2010, Pages 1088-1094

  Cosio, Fernando G ^a   Lager, Donna J ^a   Lorenz, Elizabeth C ^a   Amer, Hatem ^a   Gloor, James M ^a   Stegall, Mark D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute rejection; Anti HLA antibodies; C4d; Capillaritis; Humoral rejection

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIBODY;

ACUTE GLOMERULONEPHRITIS; ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CAPILLARITIS; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AUTOANTIBODIES; CADAVER; CAPILLARIES; COMPLEMENT C4B; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; PEPTIDE FRAGMENTS; SURVIVORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77951879280     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d368f1     Document Type: Article

References (24)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
2. Halloran PF, Wadgymar A, Ritchie S, et al. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990; 49: 85.
3. Halloran PF, Schlaut J, Solez K, et al. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53: 550.
4. Feucht HE, SchneebergerH,HillebrandG,etal. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
5. Collins A, Schneeberger E, Pascual M, et al. Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208.
6. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046.
7. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
8. Gloor J, Cosio F, Lager DJ, et al. The spectrum of antibody-mediated renal allograft injury: Implications for treatment. Am J Transplant 2008; 8: 1367.
9. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
10. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria\An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
11. Fidler ME, Gloor JM, Lager DJ, et al. Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation. Am J Transplant 2004; 4: 101.
12. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Sub-clinical incidence and association with alloantibody. Am J Transplant 2007; 9: 2124.
13. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
14. Crespo M, Pascual M, Tolkoff-Rubin N, et al. Acute humoral rejection in renal allograft recipients. I. Incidence, serology and clinical characteristics. Transplantation 2001; 71: 652.
15. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779.
16. Cosio FG, Grande JP, Wadei H, et al. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464.
17. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
18. Cosio FG, Gloor JM, Sethi S, et al. Transplant glomerulopathy. Am J Transplant 2008; 8: 492.
19. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: Predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7: 385.
20. Rother RP, Arp J, Jiang J, et al. C5 blockade with conventional immu-nosuppression induces long-term graft survival in presensitized recipients. Am J Transplant 2008; 8: 1129.
21. Issa N,Cosio FG, Gloor JM, et al. Transplant glomerulopathy: Risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 2008; 86: 681.
22. El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9: 527.
23. Shishido S, Asanuma H, Nakai H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046.
24. Moreso F, Ibernon M, Goma M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747.